Mercury Computer Systems logo. (PRNewsFoto) CHELMSFORD, MA USA

  Turnkey Imaging Applications Leverage Accelerated 3D Rendering to Optimize
                              Clinical Workflow

    CHICAGO, Ill., Nov. 28 /PRNewswire-FirstCall/ -- Mercury Computer Systems
(NASDAQ: MRCY) today introduced the ExamineRT(TM) family of OEM-tuned turnkey
applications for advanced medical imaging. The ExamineRT software application
provides advanced, accelerated visualization capabilities, server and thin-
client support, and complete digital imaging and communications in medicine
(DICOM) integration, resulting in optimized workflow and increased
productivity for OEM applications in diagnostic, interventional, and molecular
imaging, as well as for picture archiving and communication systems (PACS).
    ExamineRT applications leverage the full potential of Mercury's
comprehensive product portfolio for life sciences by integrating Mercury's
highly optimized VisageRT(TM) software components with an easy-to-use,
interactive graphical user interface that fits seamlessly into the clinical
workflow. Furthermore, ExamineRT solutions are optimized for certified
acceleration hardware, such as Mercury GPeXpress(TM) accelerators and XBi
high-density imaging platforms. The software runs on standalone workstations
as well as on a scalable application server that can be connected to multiple
thin clients, i.e., distributing highest end graphics performance to a large
number of standard PCs in a hospital environment.
    "Our strategy is to provide turnkey, customized solutions," said Marcelo
G. Lima, vice president of Life Sciences, Imaging and Visualization Solutions,
Mercury Computer Systems. "Based on the ExamineRT application, a modality
console, diagnostic or interventional workstation, or PACS viewer can provide
an individualized look and feel for each OEM customer."
    The ExamineRT product family delivers certified quality and scalable
performance, demonstrating Mercury's dedication to customer success. The
comprehensive turnkey offering, packaged as software-only, software with
accelerators, or fully integrated systems, guarantee extremely short time to
market and optimal price-performance.
    Mercury will hold demonstrations on its new life sciences solutions,
including the latest acceleration technology, scalable imaging servers,
embedded software components, and turnkey medical workstation software, in
booth #2775 at the annual meeting of the Radiological Society of North America
(RSNA), to be held November 28 to December 3 in Chicago, Illinois. Visit
http://www.mc.com/rsna for more information.
    For more information on Mercury's life sciences solutions, contact Mercury
or visit lifesciences.mc.com.

    About Mercury Computer Systems, Inc.
    Mercury Computer Systems, Inc. (NASDAQ: MRCY) is the leading provider of
high-performance embedded, real-time digital signal and image processing
computer systems. Mercury's products play a critical role in a wide range of
applications, transforming sensor data to information for analysis and
interpretation. In military reconnaissance and surveillance platforms the
Company's systems process real-time radar, sonar, and signals intelligence
data. Mercury's systems are also used in state-of-the-art medical diagnostic
imaging devices including MRI, CT, PET, and digital X-ray, and in
semiconductor imaging applications including photomask generation and wafer
inspection. Mercury provides advanced 3D image processing and visualization
software and optimized systems to diverse end markets including life sciences,
geosciences, and simulation. The Company also provides radio frequency (RF)
products for enhanced communications capabilities in military and commercial
applications.
    Based in Chelmsford, Massachusetts, Mercury serves customers in North
America, Europe and Asia through its direct sales force and a network of
subsidiaries and distributors. Visit Mercury on the web at http://www.mc.com.

    Forward-Looking Safe Harbor Statement
    This press release contains certain forward-looking statements, as that
term is defined in the Private Securities Litigation Reform Act of 1995,
including those relating to Mercury's life sciences products and services. You
can identify these statements by our use of the words "may," "will," "should,"
"plans," "expects," "anticipates," "continue," "estimate," "project,"
"intend," and similar expressions. These forward-looking statements involve
risks and uncertainties that could cause actual results to differ materially
from those projected or anticipated. Such risks and uncertainties include, but
are not limited to, general economic and business conditions, economic and
technological cycles of the life sciences markets, competition, changes in
technology, delays in completing engineering and manufacturing programs,
continued success in technological advances and delivering technological
innovations, market acceptance of the Company's products, shortages in
components, production delays due to performance quality issues with
outsourced components, and changes in applicable health care laws and
regulations or the administration of health care programs. These risks and
uncertainties also include such additional risk factors as are discussed in
the Company's recent filings with the U.S. Securities and Exchange Commission,
including its Quarterly Report on Form 10-Q for the quarter ended September
30, 2004. The Company cautions readers not to place undue reliance upon any
such forward-looking statements, which speak only as of the date made. The
Company undertakes no obligation to update any forward-looking statement to
reflect events or circumstances after the date on which such statement is
made.

     Contacts:
     Kathy Donahue                      Troy McCombs
     Mercury Computer Systems, Inc.     Coltrin & Associates
     978-967-1126                       212-221-1616

    ExamineRT, GPeXpress, and VisageRT are trademarks of Mercury Computer
Systems, Inc. Product and company names mentioned may be trademarks and/or
registered trademarks of their respective holders.

Link to this page: